AIM WINNERS & LOSERS: Genedrive shares jump on orders
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read moreTue, 03rd Dec 2019 09:39
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read moreGenedrive PLC - Manchester, England-based molecular diagnostics company - Says initial orders of its MT-RNR1 products from France, Austria, the Netherlands, Greece, Saudi Arabia and Turkey have been received. News follows confirmation that commercial distribution agreements were signed in multiple countries for Genedrive's test for antibiotic induced hearing loss. Genedrive says these initial orders will support its international distribution partners in promotion and in-country evaluation activities in their respective countries. Hopes this will "provide more extensive access to this life-changing test."
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read more(Alliance News) - Genedrive PLC on Thursday reported a widened loss but said it remains focused on investing in product development, focusing on maximising the benefits of its platform.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read moreFriday 24 November | |
no events scheduled | |
Monday 27 November | |
Celebrus Technologies PLC | Half Year Results |
DSW Capital PLC | Half Year Results |
JLEN Environmental Assets Group Ltd | Half Year Results |
Northern Bear PLC | Half Year Results |
Rightmove PLC | Trading Statement |
Serinus Energy PLC | Q3 Results |
SysGroup PLC | Half Year Results |
Tuesday 28 November | |
Altitude Group PLC | Half Year Results |
Augmentum Fintech | Half Year Results |
Brickability Group PLC | Half Year Results |
DP Eurasia NV | Trading Statement |
easyJet PLC | Full Year Results |
Focusrite PLC | Full Year Results |
Greencore Group PLC | Full Year Results |
IG Design Group PLC | Half Year Results |
Kinovo PLC | Half Year Results |
Loungers PLC | Half Year Results |
Mercia Asset Management PLC | Half Year Results |
Pets At Home Group PLC | Half Year Results |
Renew Holdings PLC | Full Year Results |
Safestore Holdings PLC | Trading Statement |
Supreme PLC | Half Year Results |
Topps Tiles PLC | Full Year Results |
Treatt PLC | Full Year Results |
Vp PLC | Half Year Results |
Wednesday 29 November | |
Amaroq Minerals Ltd | Q3 Results |
Benchmark Holdings PLC | Full Year Results |
Braemar PLC | Half Year Results |
Cordiant Digital Infrastructure Ltd | Half Year Results |
CVS Group PLC | Trading Statement |
Halfords Group PLC | Half Year Results |
Harbour Energy PLC | Trading Statement |
Pennon Group PLC | Half Year Results |
Vinanz Ltd | Q3 Results |
Thursday 30 November | |
Carclo PLC | Half Year Results |
Dr Martens PLC | Half Year Results |
Genedrive PLC | Full Year Results |
James Latham PLC | Half Year Results |
LXi REIT PLC | Half Year Results |
ME Group International PLC | Trading Statement |
TClarke PLC | Trading Statement |
Tharisa PLC | Full Year Results |
Walker Crips Group PLC | Half Year Results |
Zoo Digital Group PLC | Half Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
Genedrive PLC - Manchester-based molecular diagnostics company - Confirms that it expects to benefit from GBP1.2 million of funding, through its participation in a multi-partner grant award from Innovate UK and the UK government Innovation Accelerator programme. The grant, which is for the development and validation of technology for time critical genomic testing, will provide Genedrive with acute care patient access and supporting infrastructure to assess the real world clinical performance of time-critical clinical tests in NHS settings.
Read more(Alliance News) - Genedrive PLC on Monday said it appointed James Cheek as its new chief executive officer, effective immediately.
Read more(Sharecast News) - Point-of-care molecular diagnostics developer Genedrive announced on Wednesday that its Genedrive CYP2C19 System has received UKCA marking registration.
Read more(Alliance News) - Genedrive PLC on Wednesday said that its CYP2C19 point of care test achieved marking registration in the UK, known as UKCA.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Molecular diagnostics company Genedrive announced the latest drawdown of £0.3m under its £5m equity prepayment facility on Wednesday.
Read more(Sharecast News) - Molecular diagnostics specialist Genedrive announced its involvement in a multi-partner grant award called DEVOTE on Friday, supported by Innovate UK and the UK government's Innovation Accelerator programme.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Read moreGenedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Awarded a multi-partner grant for the validation of its CYP2X19 ID kit from Innovate UK and the UK government Innovation Accelerator programme. Says the 'Devote' grant will allow it to offer critical clinical tests in NHS settings.
Read more